doi:10.1016/j.jpba.2021.114136 63
These have their own absorption considerations, but some patients find them easier to use consistently
In a head-to-head trial against semaglutide (the SURPASS-2 trial), tirzepatide produced significantly greater weight loss, with participants taking the highest dose of tirzepatide losing an average of 11.2 kg (24.7 lbs), compared to 5.7 kg (12.5 lbs) for those taking semaglutide 1 mg
Unfolding protein folding
Post-meal walks: 10 to 20 minutes of walking after lunch and dinner blunts the glucose and triglyceride spikes from meals, reducing the substrate that would otherwise be stored as visceral fat
Zhang R, Larsen JT, Kuja-Halkola R, Thornton L, Yao S, Larsson H, et al